More people in the United States are on antidepressants, as a percentage of the population, than any other country in the world. And yet the drugs’ efficacy has been hotly debated.
Some believe that the short-term benefits are much more modest than widely thought, and that harms may outweigh benefits in the long run. Others believe that they work, and that they can be life-changing.
Settling this debate has been much harder than you might think.
[For more on this story by Aaron E. Carroll, go to https://www.nytimes.com/2018/0...ncollection%2Fhealth]
Comments (0)